Necroptotic–Apoptotic Regulation in an Endothelin-1 Model of Cerebral Ischemia

• Published in: Cellular and molecular neurobiology 2021-11, Vol.41 (8), p.1727-1742
• Main Authors: Dojo Soeandy, Chesarahmia, Elia, Andrew J., Cao, Yanshan, Rodgers, Christopher, Huang, Shudi, Elia, Andrea C., Henderson, Jeffrey T.
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis; Apoptosis - drug effects; Apoptosis - physiology; Biomedical and Life Sciences; Biomedicine; Brain injury; Brain Ischemia - chemically induced; Brain Ischemia - metabolism; Brain Ischemia - pathology; Caspase-3; Caspase-7; CD11b antigen; Cell Biology; Cell death; Electron microscopy; Endothelin 1; Endothelin-1 - toxicity; Endothelins; Female; Inflammation; Ischemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necroptosis; Necrosis - chemically induced; Necrosis - metabolism; Necrosis - pathology; Neurobiology; Neurosciences; Original Research; Phosphorylation; Receptor-Interacting Protein Serine-Threonine Kinases - metabolism; Reperfusion
• ISSN: 0272-4340; 1573-6830
• DOI: 10.1007/s10571-020-00942-y

The primary forms of cell death seen in ischemic stroke are of two major types: a necrotic/necroptotic form, and an apoptotic form that is frequently seen in penumbral regions of injury. Typically apoptotic versus necroptotic programmed cell death is described as competitive in nature, where necroptosis is often described as playing a backup role to apoptosis. In the present study, we examined the relationship between these two forms of cell death in a murine endothelin-1 model of ischemia–reperfusion injury in wildtype and caspase-3 null mice with and without addition of the pharmacologic RIPK1 phosphorylation inhibitor necrostatin-1. Analyses of ischemic brain injury were performed via both cellular and volumetric assessments, electron microscopy, TUNEL staining, activated caspase-3 and caspase-7 staining, as well as CD11b and F4/80 staining. Inhibition of caspase-3 or RIPK1 phosphorylation demonstrates significant neural protective effects which are non-additive and exhibit significant overlap in protected regions. Interestingly, morphologic analysis of the cortex demonstrates reduced apoptosis following RIPK1 inhibition. Consistent with this, RIPK1 inhibition reduces the levels of both caspase-3 and caspase-7 activation. Additionally, this protection appears independent of secondary inflammatory mediators. Together, these observations demonstrate that the necroptotic protein RIPK1 modifies caspase-3/-7 activity, ultimately resulting in decreased neuronal apoptosis. These findings thus modify the traditional exclusionary view of apoptotic/necroptotic signaling, revealing a new form of interaction between these dominant forms of cell death.